New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
16:17 EDTAEZSAeterna Zentaris announces at the market issuance program
Aeterna Zentaris announced that it has entered into an at the market issuance sales agreement with MLV & Co. under which the company may, at its discretion, from time to time during the term of the sales agreement, sell up to a maximum of 14.02M of its common shares through ATM issuances up to an aggregate amount of $15M. MLV will act as sales agent for any sales made under the ATM. The common shares will be sold at market prices prevailing at the time of the sale of common shares, and, as a result, prices may vary.
News For AEZS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
07:31 EDTAEZSAeterna Zentaris recruited 500 patients for pivotal Phase 3 ZoptEC study
Subscribe for More Information
June 25, 2015
07:37 EDTAEZSAeterna Zentaris selects Ergomed to conduct Phase 3 clinical trial of Macrilen
Aeterna Zentaris announced that it has executed a definitive agreement with Ergomed, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen, a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use